» Articles » PMID: 36384807

Economic Evaluation of Implementation Science Outcomes in Low- and Middle-income Countries: a Scoping Review

Abstract

Background: Historically, the focus of cost-effectiveness analyses has been on the costs to operate and deliver interventions after their initial design and launch. The costs related to design and implementation of interventions have often been omitted. Ignoring these costs leads to an underestimation of the true price of interventions and biases economic analyses toward favoring new interventions. This is especially true in low- and middle-income countries (LMICs), where implementation may require substantial up-front investment. This scoping review was conducted to explore the topics, depth, and availability of scientific literature on integrating implementation science into economic evaluations of health interventions in LMICs.

Methods: We searched Web of Science and PubMed for papers published between January 1, 2010, and December 31, 2021, that included components of both implementation science and economic evaluation. Studies from LMICs were prioritized for review, but papers from high-income countries were included if their methodology/findings were relevant to LMIC settings.

Results: Six thousand nine hundred eighty-six studies were screened, of which 55 were included in full-text review and 23 selected for inclusion and data extraction. Most papers were theoretical, though some focused on a single disease or disease subset, including: mental health (n = 5), HIV (n = 3), tuberculosis (n = 3), and diabetes (n = 2). Manuscripts included a mix of methodology papers, empirical studies, and other (e.g., narrative) reviews. Authorship of the included literature was skewed toward high-income settings, with 22 of the 23 papers featuring first and senior authors from high-income countries. Of nine empirical studies included, no consistent implementation cost outcomes were measured, and only four could be mapped to an existing costing or implementation framework. There was also substantial heterogeneity across studies in how implementation costs were defined, and the methods used to collect them.

Conclusion: A sparse but growing literature explores the intersection of implementation science and economic evaluation. Key needs include more research in LMICs, greater consensus on the definition of implementation costs, standardized methods to collect such costs, and identifying outcomes of greatest relevance. Addressing these gaps will result in stronger links between implementation science and economic evaluation and will create more robust and accurate estimates of intervention costs.

Trial Registration: The protocol for this manuscript was published on the Open Science Framework. It is available at: https://osf.io/ms5fa/ (DOI: 10.17605/OSF.IO/32EPJ).

Citing Articles

A scoping review on implementation processes and outcomes of models of care for low back pain in primary healthcare.

Duarte S, Moniz A, Costa D, Donato H, Heleno B, Aguiar P BMC Health Serv Res. 2024; 24(1):1365.

PMID: 39516802 PMC: 11549756. DOI: 10.1186/s12913-024-11764-9.


Challenges and recommendations for collecting and quantifying implementation costs in practice: a qualitative interview study.

Donovan T, Carter H, McPhail S, Abell B Implement Sci Commun. 2024; 5(1):114.

PMID: 39394175 PMC: 11468373. DOI: 10.1186/s43058-024-00648-y.


Exploring the return-on-investment for scaling screening and psychosocial treatment for women with common perinatal mental health problems in Malawi: Developing a cost-benefit-calculator tool.

Bauer A, Knapp M, Weng J, Ndaferankhande D, Stubbs E, Gregoire A PLoS One. 2024; 19(8):e0308667.

PMID: 39133683 PMC: 11318890. DOI: 10.1371/journal.pone.0308667.


Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case Study.

Khan Z, Kidholm K, Pedersen S, Haga S, Drozd F, Sundrehagen T Pharmacoeconomics. 2024; 42(6):663-678.

PMID: 38530596 PMC: 11126496. DOI: 10.1007/s40273-024-01366-y.


Economic evaluations performed alongside randomized implementation trials in clinical settings: a systematic review.

Carrandi A, Grove A, Skouteris H, Melder A, Hu Y, Dever M Implement Sci Commun. 2024; 5(1):24.

PMID: 38491542 PMC: 10943844. DOI: 10.1186/s43058-024-00562-3.


References
1.
Saldana L . The stages of implementation completion for evidence-based practice: protocol for a mixed methods study. Implement Sci. 2014; 9(1):43. PMC: 4234147. DOI: 10.1186/1748-5908-9-43. View

2.
Sohn H, Tucker A, Ferguson O, Gomes I, Dowdy D . Costing the implementation of public health interventions in resource-limited settings: a conceptual framework. Implement Sci. 2020; 15(1):86. PMC: 7526415. DOI: 10.1186/s13012-020-01047-2. View

3.
Sivalogan K, Semrau K, Ashigbie P, Mwangi S, Herlihy J, Yeboah-Antwi K . Influence of newborn health messages on care-seeking practices and community health behaviors among participants in the Zambia Chlorhexidine Application Trial. PLoS One. 2018; 13(6):e0198176. PMC: 6002239. DOI: 10.1371/journal.pone.0198176. View

4.
Hoomans T, Ament A, Evers S, Severens J . Implementing guidelines into clinical practice: what is the value?. J Eval Clin Pract. 2010; 17(4):606-14. DOI: 10.1111/j.1365-2753.2010.01557.x. View

5.
Oxlade O, Benedetti A, Adjobimey M, Alsdurf H, Anagonou S, Cook V . Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. Lancet Public Health. 2021; 6(5):e272-e282. DOI: 10.1016/S2468-2667(20)30261-9. View